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)) 1. INTRODUCTION
1.1 Classic ischaemic preconditioning:
Ischaem ic preconditioning (IPC) describes the endogenous adaptation of the 
m yocardium  and was firs t described by M urry et al. as increased m yocardial 
to lerance to  a severe ischaem ic insult tha t fo llow s short bouts o f non-lethal 
ischaem ia-reperfusion cycles. Now term ed classic preconditioning, it appears to  be 
an acute and im m ediate response lasting not m ore than a few  hours. The protection 
has been evoked by various preconditioning protocols and tested using diffe rent end­
points such as lim ita tion in in farct size, reduced susceptib ility to arrhythm ia, better 
recovery from  contractile  dysfunction and cardiac enzym e release.
The in tensive investigations tha t follow ed the orig ina l report by M urry have led to  the 
em ergence of several hypotheses regarding the m echanism  behind th is  com plex 
phenom enon. L ike ly triggers include adenosine, catecholam ines, bradykinin, opioids, 
oxygen free  rad ica ls (OFR), and n itric  oxide. M ost act through 7 trans-m em brane 
receptor, lead to  phospholipase C o r D (PLC o r PLD) activation, which in turn 
generates d iacylg lycero l (DAG ). DAG m ay then act on various isoenzym es of protein 
kinase C (PKC). It is believed tha t PKC activation and translocation is an im portant 
denom inator in the preconditioning cascade in a num ber of species. A nother kinase 
tha t m ay be acting e ithe r downstream  of, o r in concert to  PKC, is protein tyrosine 
kinase (PTK). It is  believed tha t PKC and PTK phosphorlate other kinase, including 
p38 m itogen activa to r prote in kinase (p38 MAP kinase), and eventually leads to the 
opening of the  m itochondria ATP-sensitive potassium  (K atp) channels. KAtp channel 
opening is believed to  be the key effector in conferring early protection to  the 
m yocardium , although recent evidence suggests otherw ise. C learly further 
investigation is m erited to  define the com plex m echanism s that confer early 
protection.
1.2 Delayed Ischaemic preconditioning:
In 1993 it was observed tha t a second wave of protection appears 24 hours follow ing 
the preconditioning protocol. T h is second wave o f protection is now referred to  as the 
second w indow  o f protection (SW OP). SW OP appears gradually, yet lasts as long as 
72 hours o r m ore. A fundam ental d ifference between classic and delayed 
preconditioning m ay be in the m eans by which cardioprotection is conveyed. In the 
form er, Katp channels are suspected to  be the end-effectors, in the la tte r newly 
synthesised card io-protective prote ins are thought to  convey protection.
L ite rature data im plies tha t both classic and delayed IPC share m any common 
triggers and m ediators. Adenosine, as w ith classic IPC, is thought to  be a m ajor 
con tribu to r to  the  induction o f SW OP. A part from  its im portance in antiarrhythm ic 
m odels, n itric  oxide (NO) has also been shown to  trigge r delayed protection against 
both m yocardia l stunning and necrosis. However w ith respect to  the role of oxygen 
free radicals in SW OP, com paratively little  has been done.
It is in teresting tha t in the  la te 80’s Szekeres et al. published data on an extensive 
study describ ing the so called "la te  appearing and long lasting” protective effects of 
prostacyclin against e lectrophysio logicai changes. Perhaps an early observation of
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w hat la te r becam e known as SW OP. O ther possib le avenues of conveying delayed 
protection exist o r are ye t to  be explored, yet w hat rem ains a challenge is perhaps 
susta in ing a preconditioned state through c lin ica lly  applicable m eans. To tha t end a 
thorough understanding of its  in trica te  in te r-ce llu la r pathways is needed.
S im ila r to  classic preconditioning, PKC activation seem s pivotal in delayed 
preconditioning. Protein tyrosine kinase has also been im plicated, along w ith 
downstream  activa tion o f m itogen activa tor prote in kinases. O verwhelm ing evidence 
supports the  hypothesis tha t delayed protection is associated w ith acquisition of 
new ly synthesised cytoprotective proteins o r a lte rations in the ir activ ity. They include 
the heat shock prote in fam ily (such as HSP72), m anganese-superoxide dism utase 
(M n-SO D), and m ore recently n itric  oxide synthase (NOS).
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2. OVERALL AIM OF THE PROJECTS))
Extensive research over the  years in the fie ld  o f ischaem ic preconditioning has 
greatly extended our understanding o f the underlying m echanism  of cardiac 
adaptation. A lthough m any questions are yet to  be elucidated, especially w ith regard 
to  the second w indow of protection, it rem ains one of the m ost pow erful experim ental 
tools in cytopro tection tha t m ay one day transla te  into a c lin ica l reality.
In our firs t series of SW OP investigations, we aim ed to define the role of oxygen free 
rad ica ls as triggers of th is  adaptive process. Num erous studies suggest tha t OFR can 
trigger classic ischaem ic preconditioning. T he ir role in delayed IPC though has been 
som ewhat under-investigated. S ince convincing evidence suggests tha t OFR m ay 
lead to activa tion of transcription factors thus leading to  enhanced cytoprotective 
protein synthesis, which are like ly to  convey delayed protection, a role fo r OFR in 
SWOP is  very plausible.
In the second series o f investigations, we set upon exam ining SW OP in a swine 
m odel. P revious attem pts at inducing delayed IPC in pig m yocardium  had thus fa r 
fa iled  to yie ld  m eaningful protection against in farction. Nonetheless since sw ine heart 
close ly resem bles tha t o f adu lt human heart, a successful dem onstration o f SWOP in 
p ig m yocardium  w ould fu rthe r fue l in terest in  delayed preconditioning and its potential 
c lin ica l application. In addition we aim ed to  convey delayed protection em ploying a 
m edica lly applicab le technique (Percutaneous Translum inal Coronary Angiography, 
PTCA). W e hypothesised tha t w ith the right protocol, pig m yocardium , as w ith other 
species, m ay be am enable to  delayed protection. Furtherm ore we aim ed to  exam ine 
if a subthershold ischaem ic stim ulus (2x2 m in) can be augm ented pharm acologically 
to induce fu ll protection against a severe ischaem ic insult, which can perhaps be 
in terpreted as a step c loser towards realizing the c lin ica l application of th is powerful 
response.
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3. DO OXYGEN FREE RADICALS INDUCE SWOP IN DOGS?
3 .11nsight into the study:
Recently it has been suggested tha t a t low concentrations oxygen free radicals can 
m odulate functions w ith in the ce il. As previously m entioned M urry et a /w a s  the firs t 
to  investigate the ir potentia l role as triggers of classic IPC. Their role in delayed 
preconditioning however rem ains am biguous. A t low concentrations, OFR are 
thought to  d irectly activate PKC. They have also been shown to  stim ulate 
phospholipase D, which would ind irectly lead to  PKC activation. The aim  of th is study 
was to  exam ine the contribution m ade by OFR to the  induction of delayed protection 
against in fa rction in a large anim al m odel. W e tested the potential cardioprotection 
afforded by various num bers of b rie f cycles of ischaem ia-reperfusion. W e then 
investigated if the  protection was lost w ith the adm inistration of a potent free radical 
scavenger, N -2-m ercaptopropionylglÍcine (M PG), given during the preconditioning 
protocols.
3.2 Materials and methods:
A dult m ongrel dogs of e ither sex were subjected to  overnight fast p rio r to  the 
experim ents. Anim als were pre-m edicated w ith droperidol and atropine. Anesthesia 
was induced by trapanal. Anesthesia was m aintained w ith narcotan in a nitrous 
oxide:oxygen gaseous m ixture.
The experim ental protocol stretched over tw o days. On day one, under sterile 
conditions, the right fem oral a rtery was prepared and cannulated fo r system ic 
pressure m onitoring and blood w ithdraw al respectively. System ic blood pressures 
and ECG were continuously recorded. A rteria l blood pH, p02, pC 02 were m onitored 
at selected in tervals. The anim al was given a m uscle relaxant before a le ft 
thoracotom y to  expose the heart. A 0.5 cm segm ent o f the  le ft an terior descending 
coronary artery (LAD) was then care fu lly dissected. A 3-0 silk suture was passed 
around the iso lated portion of the  LAD to form  a snare. Follow ing the com pletion of 
e ithe r sham  o r ischaem ic preconditioning protocols (described below), the chest was 
closed, the  anim al allow ed to  recover.
On the fo llow ing day, a ll anim als were subjected to  60 m in ischaem ia follow ed by 180 
m in of reperfusion. Follow ing conclusion of the reperfusion period, the  heart was 
subjected to  double stain ing using patent blue dye and 1% triphenyltetrazolium  
chloride (TTC ). The percentage o f area at risk and infarction w ith in the area at risk 
was determ ined.
Transm ural blood flow  was also m easured by fluorescent m icrospheres using the 
reference w ithdraw al technique. T ransm ural flow  was m easured before ligation and 
m id-way through the sustained occlusion on day 2. The values were expressed as 
m l/m in/gram  wet tissue. Results w ere excluded from  the study if the subendocardial 
blood flow  during ligation was m ore than 0.15 m l/m in/g. In addition fo llow ing a contro l 
m easurem ent, ECG, heart rate and system ic blood pressures were registered and 
recorded at regular in trevals. The occurrence of any ventricu lar tachycardia and 
fib rilla tion  were recorded autom atically.
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A ll resu lts are expressed as mean values ±  SEM . Infarct size data were analysed 
w ith 1-way analysis o f variance (ANOVA) follow ed by unpaired t-test with 
Bonferconi’s correction fo r m ultip le com parisons. Haem odynam ic data were analysed 
using repeated m easures ANOVA. The null hypothesis was rejected when P < 0.05.
3.3 Experimental protocol:
The study was divided into two phases. In phase I, com prising of 4  groups, a model 
of delayed ischaem ic preconditioning was designed w ith various cycles of IPC:
G l- C ontro l (sham  thoracotom y)
G il- 4x5 IPC (4  x 5-m in ischaem ia, 10min reperfusion)
G lll-2x5  IPC (2 x 5-m in ischaem ia, 10min reperfusion)
G IV-1x5 IPC (1 x 5-m in ischaem ia, 10min reperfusion)
In phase II we sought to  block OFR by adm inistering an antioxidant. On day 1, N-2- 
m ercaptopropionylglicine (1.5 m g/kg/m in) was universally adm inistered as a 
continuous infusion, 30 m in prio r to  any protocol. Four groups were designed, 
reciprocal to  the fou r groups in phase I:
G V- MPG (drug contro l)
G VI- 4x5 IPC + MPG 
G V II- 2x5 IPC + MPG 
G V III- 1x5 IPC + MPG
On the second day all anim als were subjected to  a 60-m in index ischaem ia, followed 
by 180 m in of reperfusion.
3.4 Results:
Changes in heart rate, systo lic and d iasto lic blood pressures, and rate-pressure 
products were com parable across the groups and it is un like ly tha t changes in infarct 
size could be attribu ted to  haem odynam ic variations. S im ilarly the size of area at risk 
(AAR) ranging from  22.9 to  25.1% , dem onstrated tha t a ll groups were subjected to 
com parable areas at risk.
In phase I o f the  study the contro l group (n=6), showed a mean infarct size of 39.5 ±
5.1 % of the  AAR. Preconditioning w ith fou r cycles (4x5 IPC) reduced the infarction to 
15.8 ±  1.3 %  (n=6, p<0.05). S im ilarly the  2x5 IPC group (n=5), dem onstrated a 
sign ificant lim ita tion  in in farct size (11.4 ±  1.3 % , p<0.05). The 1x5 IPC also conferred 
som e protection com pared to  contro ls, however th is  reduction was not sta tistica lly 
significant
The m ean infarction values of phase II o f the study were as follow s; drug control group 
(MPG), had a m ean value com parable to  that o f the  contro ls in Phase I (37.0 ±  4.2 %, 
n=5). A ddition o f MPG had little  effect on the protection afforded by 4x5 IPC (n=6), as 
the reduction in in farction was s till s ta tistica lly sign ificant (13.7 ± 2.1 %, p<0.05). 
Adding MPG however abolished the previously observed protection w ith e ither 2x5 or 
1x5 IPC (28.8 ±  3.2 %, 36.6 ±  3.4 % respectively).
A lthough we also m onitored the incidence o f arrhythm ia and prem ature ventricular 
beats in every experim ent, it can be said tha t no specific pattern, o r significant
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difference was noted between the groups. However a d istinct pattern of reduced 
susceptib ility to  VF was seen in m ost preconditioned groups.
3 .5  Conclusions from this study:
The 4x5 and 2x5 IPC stim uli both conveyed sign ificant cardioprotection. However this 
protection d id  not reach a sign ificant level w ith a single cycle o f IPC in the dog 
m yocardium . In the second phase of the study the addition of MPG did not reverse 
the card ioprotection afforded by 4x5 IPC. However the sign ificant protection seen 
w ith 2x5 IPC and the partia l in farct lim itation afforded by 1x5 IPC were both 
abolished. Yet the re  seem s to  be dissociation in the MPG+2x5 IPC group, between 
loss of pro tection against in farction as opposed to  m aintained protection against 
ven tricu lar fib rilla tion . The reason fo r th is  observation is unclear. Nonetheless it can 
be assum ed that in dogs, generation of oxygen free radicals during the brie f cycles of 
ischaem ia-reperfusion is an in tegra l part of triggering delayed cardioprotection. 
However th is  role is  on ly crucia l w ith few er bouts o f IPC. As the num ber o f cycles rise 
(rigorous stim uli), blocking OFR seem s to  have no adverse effect on the induction of 
SW OP. W ith m ultip le cycles o ther possible triggers (e.g. adenosine, n itric  oxide etc.) 
m ight be released in su ffic ien t am ounts to  confer cardioprotection, even in the 
absence of oxygen free  radicals.
O ver the  years OFR have been shown, to  e ithe r d irectly o r ind irectly stim ulate the 
signaling cascades tha t culm inate to  IPC. One such cascade is via the activation and 
translocation of prote in kinase C, which then leads to  gene transcription, yie lding 
proteins instrum ental in delayed cardioprotection. M ore recently evidence is 
em erging on free  radicals inducing a PTK-dependent pathway leading to 
card ioprotection. Downstream  the signal transduction leads to  enhanced 
phosphorylation and activa tion o f other m ediators. The nuclear transcription factor 
NFkB has also been recognized to  p lay a crucia l role in delayed IPC. There is strong 
evidence tha t oxidative stress can also lead to  NFkB translocation and activation, 
fu rthe r proof o f the  possib le role o f OFR in triggering the ce llu la r cascades tha t lead 
to  delayed ischaem ic adaptation.
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D 4. SWOP IN PIG MYOCARDIUM
4.1 Insight into the study:
A fte r m ore than a decade, we are ye t to  reach the ultim ate goal of pharm acological 
preconditioning. B radykinin B2 receptor stim ulation has been proven to  contribute to 
induction of classic IPC. Furtherm ore it has been shown that angiotensin converting 
enzym e (ACE) inh ib ito rs confer m yocardial cytoprotection, and seem  to  do so by 
augm enting bradykinin level. Thus in an in vivo sw ine m odel, we firs t aim ed to 
establish delayed cytoprotection, using PTCA to precondition the anim als. W e then 
subjected the p igs to  a subthreshold ischaem ic stim ulus, and exam ined if the addition 
of an ACE inh ib ito r, perindoprila t (0.06 m g/kg), during the IPC protocol w ould 
augm ent the protection afforded. If so, th is w ould be the firs t study to  establish 
pharm acological enhancem ent o f a c lin ica lly  relevant subthreshold stim ulus in a 
m odel o f delayed cardioprotection.
4.2 Materials and methods:
Follow ing an overnight fast, pigs were im m obilized by adm inistration of ketam ine and 
diazepam . Anaesthesia was induced by intravenous adm inistration of thiopentone 
sodium . Surg ica l anaesthesia and ventila tion were m aintained using a gaseous 
m ixture of n itrous oxide:oxygen in addition to  1.0-1.5%  isoflurane.
This study was designed to  investigate delayed ischaem ic preconditioning in pig 
m yocardium , there fore each procedure again com prised of tw o days. On day 1, each 
anim al underw ent e ithe r sham  o r IPC procedure via em ploying percutaneous 
translum inal coronary angioplasty (PTCA). On day 2, fo llow ing a m id-line 
thoracotom y, a ll anim als w ere subjected to  40 m in ligation of le ft an terio r descending 
coronary a rte ry (LAD) fo llow ed by 180 m in o f reperfusion. Infarct size was taken as 
the  end po in t o f the  experim ent and was determ ined (as described above) fo llow ing 
com pletion o f reperfusion.
To fu rthe r e laborate on the  induction of delayed adaptation in th is  m odel, we also 
investigated one o f the proposed end-effectors of th is  process, nam ely Mn-SOD 
content in cardiom yocytes. In every group additional tw o pigs were subjected to 
relevant procedures on day 1. On day 2 fo llow ing anaesthesia the chest was opened 
and the  heart was extracted. Sam ples were taken and sent fo r im m unohistochem ical 
investigations.
Throughout the procedure standard lim b ECG and system ic blood pressures (BP) 
were m onitored continuously. A rteria l p 0 2 and pH were m aintained w ith in the 
physio logic range. In case of ventricu lar fib rilla tion  (VF), if de fib rilla tion  could not be 
accom plished w ith in  60 seconds, the experim ent was term inated. S im ilar statistica l 
evaluations, as em ployed in the firs t series of investigations, were applied in th is 
study.
4.3 Experimental protocol:
Five groups were designed to  determ ine if pig m yocardium  can convey delayed 
card ioprotection, and furtherm ore whether a subtheshold ischaem ic stim ulus (2x2 
IPC) can be augm ented pharm acologically to  convey significant protection;
G l- contro l (sham  PTCA)
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G il- 4x5 iPC  (4 x  5-m in ischaem ia, 10min reperfusion)
G ill-2x2  IPC (2 x2 -m in  ischaem ia, 10min reperfusion)
G IV- perindoprila t (drug control)
G V- 2x2 IPC + P erindoprilat
A ll anim als w ere subjected to  the sam e protocol on day 2 as described above.
4.4 Resuits:
H eart rate and system ic blood pressures w ere m onitored continuously and recorded 
at regular in terva ls, however there were no sign ificant differences between the values 
at any g iven in te rva l between the groups. S im ilarly mean AAR values were 
com parable across the  groups.
The resu lts o f the  in fa rct s ize study dem onstrate tha t in contrast to  tw o previous 
stud ies, p ig m yocardium  is a lso am enable to  delayed protection against infarction 
fo llow ing IPC. There was a s ign ificant reduction in in fa rct size from  42.8 ±  3.2%  in the 
contro l group (n=9), to  19.5 ± 3.9%  (p<0.05) in  the  4x5 IPC group (n=8). The 
subthreshold stim ulus o r perindorprila t alone could not confer significant delayed 
protection (33.4 ± 3.9% , n=7 & 31.2 ± 2.3% , n=8 respectively). However when 
com bined (2x2 IPC + Pr.), they conferred sign ificant protection against in farction 
(18.4 ±  3.1% , p<0.05, n=7). T h is protection was com parable w ith tha t observed in the 
fu lly  preconditioned group (4x5 IPC).
W e did not observe any sign ificant differences in reperfusion arrhythm ias and 
fib rilla tion , between preconditioned and none-preconditioned groups, thus concluding 
tha t the re  was no protection against rhythm  disturbances in th is  sw ine m odel o f 
delayed IPC.
Results from  M n-SOD im m unohistochem istry fu rthe r confirm ed the preconditioned . 
state. The preconditioned groups showed fa r stronger positiv ity than non- 
preconditioned groups.
4.5 Conclusions from this study:
The second window of protection may also be evoked in porcine myocardium, as evident 
from the protection against infarction. This observation is further substantiated with increased 
Mn-SOD in preconditioned hearts. Secondly and perhaps medically more significant, we were 
able to pharmacologically augment a clinically relevant (subthershold) ischaemic stimulus in 
a model of delayed adaptation. The 2x2 min IPC chosen as our subthreshold stimulus is 
realistic and closely resembles clinical interventions performed on patients with ischaemic 
heart disease (e.g. PTCA). There are two reasons as to why we chose an ACE inhibitor in our 
model. First, since their introduction, they have become a cornerstone in treatment of 
hypertension. ACE inhibitors have also emerged as a crucial part of therapy in patients 
suffering from heart failure. They have been shown to prevent left ventricular remodeling as 
well as reduce myocardial ischaemic events. Thus they have become an indispensable tool in
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treating patients-with heart disease. To leam more of their potential role in delayed 
cardioprotection can be beneficial to millions of people worldwide. On the other hand ACE 
inhibitors have been shown to induce early protection in the setting of classic IPC. These 
considerations were the impetus behind our choice of pharmacological preconditioning in this 
model. Pharmacological preconditioning in humans may be a future option for adjunct 
therapy, and as demonstrated by this study, it is not an unattainable goal. On the other hand on 
a daily basis patients with ischaemic heart disease may be subjected to brief bouts of 
ischaemia (electively in the form of PTCA or non-electively in the form of angina pectoris). 
These short ischaemic episodes may simulate subthreshold preconditioning stimuli that along 
with the right measures could be enhanced pharmacologically to the benefit of the patient.
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5. NOVEL HNDING S ))
•  In our firs t series o f experim ents we were able to dem onstrate tha t oxygen free 
radicals p lay a crucia l role in the induction o f delayed cardioprotection against 
in fa rction in an in vivo dog m odel. This protection was seen as tolerance against 
both in fa rction as w ell as ventricu lar fib rilla tion  24 hours follow ing ischaem ic 
preconditioning. However as dem onstrated, the role played by free radicals is 
overwhelm ed by o ther triggers during m ultip le cycles of IPC.
•  In the second series of experim ents, delayed cardioprotection was dem onstrated 
fo r the firs t tim e in  pig m yocardium . A lthough there was a c lear lim itation of the 
in fa rct size in preconditioned pigs, we did not observe an increased tolerance 
against reperfusion arrhythm ias o r fib rilla tions.
•  A lso novel to  th is work was the dem onstration of pharm acological enhancement 
o f subthreshold ischaem ic stim uli in  a m odel o f delayed cardiac adaptation. The 
use o f an ACE inh ib ito r to  achieve th is augm entation adds to  the clin ica l 
im portance of th is observation.
•  Based on previous results regarding blunted breakdown of bradykinin follow ing 
pretreatm ent w ith ACE inh ib itors, th is  study fo r the firs t tim e hints a t the possible 
involvem ent o f bradykinin in the induction o f the second window o f protection.
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